• LOGIN
    Login with username and password
Repository logo

BORIS Portal

Bern Open Repository and Information System

  • Publications
  • Theses
  • Research Data
  • Projects
  • Organizations
  • Researchers
  • More
  • Collections
  • Statistics
  • LOGIN
    Login with username and password
Repository logo
Unibern.ch
  1. Home
  2. Publications
  3. Self Made Xeno-pericardial Aortic Tubes to Treat Native and Aortic Graft Infections.
 

Self Made Xeno-pericardial Aortic Tubes to Treat Native and Aortic Graft Infections.

Options
  • Details
  • Files
BORIS DOI
10.7892/boris.105415
Publisher DOI
10.1016/j.ejvs.2017.07.017
PubMed ID
28874328
Description
OBJECTIVES

The most appropriate material for reconstruction of the aorta for native or graft infection remains a matter for debate. This study examines the mid-term outcome of patients and graft durability after in situ aortic reconstruction with self made bovine pericardial tube grafts.

METHODS

This was a retrospective analysis of all patients who underwent in situ aortic reconstruction using self made bovine pericardial tube grafts between January 2008 and December 2015 at a tertiary referral centre. Peri-operative and mid-term outcomes including mortality and re-infection were analysed at the end of January 2017. Available follow-up imaging was reviewed to assess graft durability.

RESULTS

Bovine pericardial aortic tube grafts were used in 35 patients (86% male) with a median age of 69 years (range 38-84) to reconstruct the ascending aorta or the aortic arch (7), the descending (7), the thoraco-abdominal (7), or the abdominal (14) aorta. Twelve patients (34%) were treated for infection of the native aorta and 23 (66%) for prosthetic graft infection. Twenty-two patients (63%) underwent emergency surgery. Thirty day mortality was 31% (n = 11). Additionally, six patients died during follow-up after a median of 33 months (range 3-70). For the remaining patients, mean follow-up was 48 months (± 26) with a mean Follow-Up Index of 0.98 ± 0.08. There were no readmissions or re-operations for re-infection or graft related complications. Follow-up imaging showed no signs of graft degeneration after a median of 15 months (range 3-68).

CONCLUSIONS

Surgical treatment of native and aortic graft or endograft infection remains high risk. Self made bovine pericardial tube grafts for in situ reconstruction are a promising option offering many advantages. Despite high early mortality rates, early radiological and mid-term clinical results are good. Definitive eradication of the infection seems feasible after in situ insertion of xeno-pericardial material for aortic repair.
Date of Publication
2017-11
Publication Type
Article
Subject(s)
600 Technology > 610 Medicine & health
Keyword(s)
Aneurysm Aortic reconstruction Bioprosthesis Infected Pericardium/transplantation Prosthesis related infections
Language(s)
en
Contributor(s)
Weiss, Salome
Universitätsklinik für Herz- und Gefässchirurgie
Tobler, Eva-Luca
von Tengg-Kobligk, Hendrikorcid-logo
Universitätsinstitut für Diagnostische, Interventionelle und Pädiatrische Radiologie
Makaloski, Vladimir
Universitätsklinik für Herz- und Gefässchirurgie
Becker, Daniel
Universitätsklinik für Herz- und Gefässchirurgie
Carrel, Thierry
Universitätsklinik für Herz- und Gefässchirurgie
Schmidli, Jürg
Universitätsklinik für Herz- und Gefässchirurgie
Wyss, Thomas
Universitätsklinik für Herz- und Gefässchirurgie
Additional Credits
Universitätsklinik für Herz- und Gefässchirurgie
Universitätsinstitut für Diagnostische, Interventionelle und Pädiatrische Radiologie
Series
European journal of vascular and endovascular surgery EJVES
Publisher
Elsevier
ISSN
1078-5884
Access(Rights)
restricted
Show full item
BORIS Portal
Bern Open Repository and Information System
Build: dd892c [ 9.04. 8:30]
Explore
  • Projects
  • Funding
  • Publications
  • Research Data
  • Organizations
  • Researchers
  • Audiovisual Material
  • Software & other digital items
  • Events
More
  • About BORIS Portal
  • Send Feedback
  • Cookie settings
  • Service Policy
Follow us on
  • Mastodon
  • YouTube
  • LinkedIn
UniBe logo